Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis: Survival Benefit of Transarterial Chemoembolization in Combination With Irradiation Stent Placement

NCT03108248 is registered in ClinicalTrials.gov with Zhongda Hospital as lead sponsor.

NCT NCT03108248
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03108248 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis: Survival Benefit of Transarterial Chemoembolization in Combination With Irradiation Stent Placement
Lead sponsor
Zhongda Hospital
Phase
Observational
Overall status
Completed
Start date
January 1, 2011
Completion date
March 25, 2017
Enrollment
126 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hcc, portal vein tumor thrombosis